Find a Doctor or Practice Location

You can also search for providers and practices at Penn Medicine Lancaster General Health or Princeton Health.

I am searching for a
Reset Form
Robert A. Burger, MD

Robert A. Burger, MD Physician

Director of Clinical Research and Fellowship Program in Gynecologic Oncology Professor of Obstetrics and Gynecology at the Hospital of the University of Pennsylvania

Dr. Burger is employed by Penn Medicine.

About Dr. Robert A. Burger

Recognized by America's Top Doctors, 2014 - 2018

Recognized by Best Doctors in America - 2013 - 2018

Recognized by Philadelphia magazine's annual Top Docs issues 2014 - 2019

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Clinical Specialties


  • Gynecologic Oncology

Programs & Centers:

Board Certification:

  • Obstetrics and Gynecology - Gynecologic Oncology, 1999
  • Obstetrics and Gynecology, 1997

Clinical Expertise:

  • Cervical Cancer
  • Cervical Dysplasia
  • Endometrial Cancer
  • Fallopian Tube Cancer
  • Gynecologic Surgery
  • Leiomyosarcoma
  • Ovarian Cancer
  • Ovarian Tumors
  • Urethral Cancer
  • Uterine Cancer
  • Vaginal Cancer

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • eLAP Services
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Homestead Smart Health Plans
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Provider Partners Health Plan
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Veterans Choice Program

Education and Training

Medical School: New York University School of Medicine
Residency: Hospital of the University of Pennsylvania
Fellowship: UC at Irvine Medical Center


American Association for Cancer Research (AACR), National American College of Obstetricians and Gynecologists, National American College of Surgeons (FACS), fellow, National GOG Foundation, National Gynecologic Oncology Group, National National Cancer Institute (NCI), Investigator, National NRG Oncology, International NRG Oncology, National Ovarian Cancer National Alliance Scientific and Medical Advisory Board, National Society of Gynecologic Oncology (SGO), National

Hospital Affiliation

Dr. Burger is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.


Selected Publications:

Graul A, Haggerty A, Stickley C, Kumar P, Morales K, Bogner H, Burger R, Morgan M, Ko E.: Effect of patient education on palliative care knowledge and acceptability of outpatient palliative care service among gynecologic oncology patients. Poster Presentation, Annual Meeting of the American Society of Clinical Oncology. (Abstract) : 2019.

Cadoo KA, Meyers ML, Burger RA, Armstrong DK, Penson RT, Gordon MS, Fleming GF, Moroney JW, Hamilton EP, Duska LR, Wenham RM, Sankoh S, Brouwer S, Ordentlich P, Aghajanian C, Matulonis UA.: A phase II randomized study of avelumab plus entinostat versus avelumab plus placebo in patients (pts) with advanced epithelial ovarian cancer (EOC). Clinical Science Symposium Presentation at the Annual Meeting of the American Society of Clinical Oncology (Abstract) : 2019.

Nasioudis D, Ko EM, Haggerty AF, Giuntoli II RL, Burger RA, Morgan MA, Latif NA: Role of adjuvant chemotherapy in the management of stage IC ovarian granulosa cell tumors Gynecol Oncol Rep 28 : 145-148,2019.

Nasioudis D, Ko E, Haggerty AF, Giuntoli RL II, Burger RA, Morgan RA, Latif N: Isolated distant lymph node metastases in ovarian cancer. Should a new sub-stage be created? Gynecol Oncol Rep 28 : 86-90,2019.

Rose PG, Java JJ, Salani R, Geller MA, Secord AA, Tewari KS, Bender DP, Mutch DG, Friedlander ML, Van Le L, Method MW, Hamilton CA, Lee RB, Wenham RM, Guntupalli SR, Muggia FM, Armstrong DK, Bookman MA, Burger RA, Copeland LJ: Nomogram Predicting Individual Survival Following Recurrence in Advanced Stage High Grade Ovarian Cancer from NRG/GOG Randomized Trials of Platinum and Paclitaxel Obstetrics & Gynecology 133 (2): 245-54,2019.

Fuh K, Java JJ, Chan JK, Kapp DS, Monk BJ, Burger RA, Young RC, Alberts DS, McGuire WP, Markman M, Bell J, Ozols RF, Armstrong DK, Aghajanian C, Bookman MA, Mannel RS: Differences in presentation and survival of Asians compared to Caucasians with ovarian cancer: An NRG Oncology/GOG Ancillary study of 7,914 patients Gynecol Oncol In Press : 2019.

Wade K, Brady MF, Thai T, Want Y, Zheng B, Salani R, Tewari KS, Gray HJ, Bakkum-Gamez JN, Burger RA, Moore KN, Bookman MA: Measurements of adiposity as prognostic biomarkers for survival with anti-angiogenic treatment in epithelial ovarian cancer: An NRG Oncology/Gynecologic Oncology Group ancillary data analysis of GOG 218 Gynecol Oncol In Press : 2019.

Fruehauf JP, Parmakhtiar B, Burger RA, Kim J-H: HIF inactivation of p53 in Ovarian Cancer Can be Reversed by Topotecan, Restoring Cisplatin and Paclitaxel Sensitivity Molecular Cancer Research In Press : 2019.

Cori L, Cha B, Ellenberg S, Bogner HR, Hwang W-T, Smith J, Haggerty A, Morgan M, Burger RA, Chu C, Ko E: The Impact of Educational Interventions on Human Papillomavirus Vaccine Acceptability: A Randomized Controlled Trial Obstetrics and Gynecology In Press : 2019.

Gockley A, Melamed A, Cronin A, Bookman MA, Burger RA, Cristae MC, Griggs JJ, Mantia-Smaldone G, Matulonis UA, Meyer LA, Niland J, O'Malley DM, Wright AA.: Outcomes of secondary cytoreductive surgery for patients with platinum-sensitive recurrent ovarian cancer The American Journal of Obstetrics & Gynecology In Press : 2019.

Academic Contact Info

University of Pennsylvania
3400 Civic Center Blvd.
South Tower 10-173

Philadelphia, PA 19104-5156
Phone: (215) 220-9513
Patient appointments: 800-789-7366 (PENN)